Partnerships & Mergers

The agreement also supports GlobeMed Gulf’s broader strategy of expanding access to high-quality healthcare for its growing base of insured members.

The initiative will support patients with the greatest medical and financial needs by improving access to advanced therapies within a framework aligned with the UAE’s national health insurance system.

Through the partnership, the two organisations aim to bridge academic knowledge with clinical expertise while supporting innovation, talent development and improved healthcare delivery.

The agreement builds on Haleon’s existing use of Microsoft 365 Copilot and broadens the company’s adoption of Microsoft’s AI, cloud and data technologies.

The expanded label is expected to make about 5,500 additional children in the United States eligible for treatment.

The collaboration aims to turn scientific discoveries into practical healthcare solutions by combining MIT’s research expertise with Abu Dhabi’s expanding life sciences ecosystem.

Under the partnership, the two organizations will work together to enhance HMC’s Clinical Trials Unit (CTU), strengthen research expertise, and develop initiatives that support the continued growth of Qatar’s healthcare sector.

Verzenios is a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor developed by Lilly for the treatment of several forms of breast cancer.

The agreement brings together Lilly’s expertise in developing innovative medicines with Abu Dhabi’s advanced healthcare infrastructure, population-scale health data, and genomics capabilities.

Alzheimer’s disease affects more than 55 million people worldwide, and that figure is projected to nearly triple by 2050.